Table 1.
Demographics of patients and controls according to AITD and NTAID.
| Group AITD Selective NAITD |
1 (n = 66) HT or GDa CAG |
2 (n = 26) HT NSV |
3 (n = 15) HT or GDa CD |
All (n = 107) HT + GD CAG + NSV + CD |
|---|---|---|---|---|
| Other NAITD | ||||
| Only one (selective) | 42 | 24 | 15 | 76 |
| Two | 19 | 2 | 0 | 23 |
| Three | 5 | 0 | 0 | 8 |
| Four or more | 0 | 0 | 0 | 0 |
| Most frequent NAITD | ||||
| Pernicious anemia | 13 | 0 | 0 | 13 |
| Rheumatoid arthtritis | 3 | 0 | 0 | 0 |
| Sjogren syndrome | 3 | 0 | 0 | 0 |
| Other indices | ||||
| Age, years | 55.4 ± 13.6 | 45.5 ± 14.1 | 37.4 ± 12.2 | 50.5 ± 15.0 |
| Gender (females, males) (F:M ratio) | 61, 5 (12.2:1) | 16, 10 (1.6:1) | 13, 2 (6.5:1) | 90, 17 (5.3:1) |
| Under L-T4 replacement | n = 45 (68.2%) | n = 16 (61.5%) | n = 6 (40%) | n = 67 (62.6%) |
Not to overload the table we have shown only the most frequent NTAID, namely, those in ≥3 patients.
AITD, autoimmune thyroid disease; CAG, chronic autoimmune gastritis; CD, celiac disease; GD, Graves’ disease; HT, Hashimoto’s thyroiditis; NAITD, non-autoimmune thyroid disease; NSV, non-segmental vitiligo.
aOnly four patients had GD as AITD, two of them were in group 1 and another two in group 3.